Abstract
Background
Current studies have focused on the association of fibromyalgia syndrome (FMS) and obsctructive sleep apnea syndrome (OSAS). Results of these studies on the effect of this association have been inconsistent. The current study aimed to investigate the effect of FMS on OSAS regarding sleep quality, pressure pain threshold, fatigue, daytime symptoms, anxiety, and depression, and also to determine the relationship between OSAS severity and FMS.
Methods
In a cross-sectional design, patients diagnosed with OSAS were evaluated in two groups comparing those with and those without FMS. Data on demographics, headache, morning fatigue, and chronic pain duration were collected. Questionnaires including the Fatigue Severity Scale (FSS), Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) were completed. Pressure pain threshold, tender points, and polysomnographic data were recorded.
Results
Of 69 patients, 27 were diagnosed with FMS + OSAS and 42 were diagnosed as OSAS only. Statistically significant differences were found between the two groups in VAS, pain duration, morning fatigue, headache, BAI, tender point count, FIQ and FSS scores, and algometer measurements. All polysomnografic data were compared, and no statistically significant differences were found between the two groups. There were no statistically significant differences in the algometer, BDI, BAI, FIQ, and FSS scores when analyzed according to the severity of OSAS.
Conclusion
The findings suggest that FMS has no effect on polysomnographic parameters of OSAS. Headache, daytime fatigue, anxiety, depression, pain duration, and pain intensity are higher while the pressure pain threshold is lower when FMS is present. No correlation was found between OSAS severity and FMS, fatigue, pressure pain threshold, depression, and anxiety.
Clinical Trial Registration Number: NCT05367167/date: April 8, 2022.
Similar content being viewed by others
Data availability
The data of this study are available from the corresponding author upon request.
References
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MS, Morrell MJ et al (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7(8):687–698
Rundo JV (2019) Obstructive sleep apnea basics. Cleve Clin J Med 86(9 Suppl 1):2–9
Bouloukaki I, Tsiligianni I, Schiza S (2021) Evaluation of Obstructive Sleep Apnea in Female Patients in Primary Care: Time for Improvement? Med Princ Pract 30(6):508–514
Vanek J, Prasko J, Genzor S, Ociskova M, Kantor K, Holubova M et al (2020) Obstructive sleep apnea, depression and cognitive impairment. Sleep Med 72:50–58
Charokopos A, Card ME, Gunderson C, Steffens C, Bastian LA (2018) The association of obstructive sleep apnea and pain outcomes in adults: a systematic review. Pain Med 19(suppl_1):S69–S75
Meresh ES, Artin H, Joyce C, Birch S, Daniels D, Owens JH et al (2019) Obstructive sleep apnea co-morbidity in patients with fibromyalgia: a single-center retrospective analysis and literature review. Open Access Rheumatol 11:103–109
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600–610
Lichtenstein A, Tiosano S, Amital H (2018) The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol 30(1):94–100
Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F (2020) Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol 16(11):645–660
Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken) 65(5):786–792
Sarzi-Puttini P, Atzeni F, Masala IF, Salaffi F, Chapman J, Choy E (2018) Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria? Autoimmun Rev 17(1):33–35
Häuser W, Sarzi-Puttini P, Fitzcharles MA (2019) Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol. 37:90–7
Mutlu P, Zateri Ç, Zöhra A, Özerdoğan Ö, Mirici AN (2020) Prevalence of obstructive sleep apnea in female patients with fibromyalgia. Saudi Med J 41(7):740
Köseoğlu H, İnanır A, Kanbay A, Okan S, Demir O, Çeçen O et al (2017) Is there a link between obstructive sleep apnea syndrome and fibromyalgia syndrome? Turk Thorac J 18(2):40–46
Wu YL, Chang LY, Lee HC, Fang SC, Tsai PS (2017) Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies. J Psychosom Res 96:89–97
Binkiewicz-Glińska A, Bakuła S, Tomczak H, Landowski J, Ruckemann-Dziurdzińska K, Zaborowska-Sapeta K et al (2015) Fibromyalgia syndrome - a multidisciplinary approach. Psychiatr Pol 49(4):801–810
Mutlu P, Zateri C, Zohra A, Ozerdogan O, Mirici AN (2020) Prevalence of obstructive sleep apnea in female patients with fibromyalgia. Saudi Med J 41(7):740–745
Chung F, Abdullah HR, Liao P (2016) STOP-Bang Questionnaire: a practical approach to screen for obstructive sleep apnea. Chest 149(3):631–638
Acar HV, Kaya A, Yücel F, Erdem M, Günal SE, Özgen F et al (2013) Validation of the STOP-Bang questionnaire: an obstructive sleep apnoea screening tool in Turkish population. Turk J Anaesthesiol Reanim 41(4):115
Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5):1387–1394
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123
Gencay-Can A, Can SS (2012) Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatol Int 32(1):27–31
Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893
Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8(1):77–100
Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J rheumatol 18(5):728–733
Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33(2):160–172
Mottola CA (1993) Measurement strategies: the visual analogue scale. Adv Skin Wound Care 6(5):56–66
Terzi R, Yılmaz Z (2017) Evaluation of pain sensitivity by tender point counts and myalgic score in patients with and without obstructive sleep apnea syndrome. Int J Rheum Dis 20(3):340–345
Wu J, Li P, Wu X, Chen W (2015) Chronic intermittent hypoxia decreases pain sensitivity and increases the expression of HIF1α and opioid receptors in experimental rats. Sleep Breath 19(2):561–568
Garbarino S, Bardwell WA, Guglielmi O, Chiorri C, Bonanni E, Magnavita N (2020) Association of Anxiety and depression in obstructive sleep apnea patients: a systematic review and meta-analysis. Behav Sleep Med 18(1):35–57
Cetingok S, Seker O, Cetingok H (2022) The relationship between fibromyalgia and depression, anxiety, anxiety sensitivity, fear avoidance beliefs, and quality of life in female patients. Medicine (Baltimore) 101(39):e30868
Kremer M, Becker LJ, Barrot M, Yalcin I (2021) How to study anxiety and depression in rodent models of chronic pain? Eur J Neurosci 53(1):236–270
Acknowledgements
The authors would like to thank all participants.
Author information
Authors and Affiliations
Contributions
Research concept and design: BCK, FT; collection and assembly of data: NZ, BCK; data analysis and interpretation; TS: writing the article;:BCK, TS: critical revision of the article: NZ, FT; final approval of the article: BCK.
Corresponding author
Ethics declarations
Ethical approval
Ethical approval was obtained from the university ethics committee (approval number: KAEK 2022–07/69). This study was registered at Clinicaltrials.gov (Clinical Trial Registration Number: NCT05367167/date: April 8, 2022). The study was organized in accordance with the 1964 Helsinki declaration, and informed voluntary consent was obtained from all participants before starting the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cigdem Karacay, B., Sahbaz, T., Zerman, N. et al. The impact of fibromyalgia syndrome on obstructive sleep apnea syndrome in terms of pain threshold, daytime symptoms, anxiety, depression, disease severity, and sleep quality: a polysomnographic study. Sleep Breath 27, 1473–1479 (2023). https://doi.org/10.1007/s11325-023-02831-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-023-02831-2